From Distressed Debt to AI Transit: The Uneasy Evolution of Hong Kong’s MarketsGlobal Report·Aug 25 at 06:32 AM02605+13.04%025000.00%
From Nordic Gold to AI Borders: Hong Kong's Mixed Equities Seek Global HedgesGlobal Report·Aug 25 at 04:20 AM09922-0.43%02013+1.99%
Tech-Med Convergence: Ping An's AI Margin Boost and Hansoh's Clinical WinsGlobal Report·Aug 18 at 04:43 AM01833-1.30%03692-0.27%
Hong Kong Equities Diverge as Infrastructure Expands and Healthcare Faces Governance TestsGlobal Report·Aug 11 at 05:13 AM01164-6.21%01199-0.77%
Inside the Hong Kong Biotech Rebound: BeiGene's Blockbuster Earnings and Venus Medtech's New LifelineGlobal Report·Aug 11 at 04:42 AM06160-0.71%025000.00%
Survival on the Fringes: Inside Hong Kong's Uncharted Equities in 2026Global Report·Aug 4 at 04:17 AM02680+3.09%08087+10.20%
The Under-the-Radar Rotation: CNOOC, Jiumaojiu, and Hidden Pockets of Hong Kong EquitiesGlobal Report·Jul 29 at 04:19 AM80883+1.49%09922-0.43%
Venus Medtech targets China, EU regulatory filings for Venus-PowerX TAVR systemPUBT·Jul 23 at 01:07 AM025000.00%
02:00 ETVenus Medtech anuncia la finalización del reclutamiento de pacientes para el ensayo clínico de Venus-PowerXprnewswire·Jul 23 at 01:00 AM025000.00%
Divergent Signals Across Hong Kong Equities: Infrastructure Resilience vs. Consumption HeadwindsGlobal Report·Jul 22 at 04:17 AM08540-0.23%025000.00%
